Page last updated: 2024-11-06

o-methylisourea

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

O-methylisourea: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID75544
MeSH IDM0042761

Synonyms (21)

Synonym
methoxy-formamidine
o-methylisouronium
carbamimidic acid, methyl ester
o-methylisourea
FT-0695111
FT-0650414
methyl carbamimidate
carbamimidic acid methyl ester
A817287
2440-60-0
BBL009722
AKOS005716965
STL141087
carbamimidic acid,methyl ester (9ci)
0-methylisourea
o-methyl isourea
2-methyl-isourea
methyl imidocarbamate #
noname_4528
DTXSID20903781
methylcarbamimidate

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Diacetylated derivatives were 30- to 35-fold less toxic than the native toxin."( Structure-toxicity relationships of neurotoxin RTX-III from the sea anemone Radianthus macrodactylus: modification of amino groups.
Kozlovskaya, EP; Mahnir, VM, 1991
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (34)

TimeframeStudies, This Drug (%)All Drugs %
pre-199016 (47.06)18.7374
1990's5 (14.71)18.2507
2000's10 (29.41)29.6817
2010's3 (8.82)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.91

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.91 (24.57)
Research Supply Index3.56 (2.92)
Research Growth Index4.16 (4.65)
Search Engine Demand Index29.12 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.91)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other34 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]